Search research articles
Contact Us
Filters
Showing results (1-10 of 125) with videos related to
Page
of 13
Sort By:
Medical Immunology (London, England)
|
March 3, 2005
The Future of Smallpox Vaccination: is MVA the key?
Mark K Slifka
Journal of Leukocyte Biology
|
May 4, 2007
CTLA4, T cell function, and long term immunity: an interview with Dr. Mark K. Slifka. Interview by Helene F. Rosenberg
Mark K Slifka
Current Opinion in Immunology
|
July 13, 2004
Immunological memory to viral infection
Mark K Slifka
Frontiers in Immunology
|
May 17, 2014
Vaccine-mediated immunity against dengue and the potential for long-term protection against disease
Mark K Slifka
Blood
|
October 9, 2004
Differential regulation of virus-specific T-cell effector functions following activation by peptide or innate cytokines
Carol Beadling, Mark K Slifka
Archivum Immunologiae Et Therapiae Experimentalis
|
April 28, 2006
Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27
Carol Beadling, Mark K Slifka
Viral Immunology
|
September 22, 2006
Keystone conference on viral immunity: from basic mechanisms to vaccines (X7) and advances in influenza research: from birds to bench to bedside (X8) Steamboat Springs, Colorado March 28-April 2, 2006
Fei Liu, Mark K Slifka
Nature Medicine
|
October 3, 2006
Quantifying viable virus-specific T cells without a priori knowledge of fine epitope specificity
Carol Beadling, Mark K Slifka
Viral Immunology
|
July 23, 2005
Public fear of vaccination: separating fact from fiction
Ian Amanna, Mark K Slifka
Vaccine
|
April 9, 2014
How advances in immunology provide insight into improving vaccine efficacy
Mark K Slifka, Ian Amanna
Page
of 13
Search research articles
Search
Showing results (1-10 of 125) with videos related to
Sort By:
Page
of 13
Medical Immunology (London, England)
|
March 3, 2005
The Future of Smallpox Vaccination: is MVA the key?
Mark K Slifka
Journal of Leukocyte Biology
|
May 4, 2007
CTLA4, T cell function, and long term immunity: an interview with Dr. Mark K. Slifka. Interview by Helene F. Rosenberg
Mark K Slifka
Current Opinion in Immunology
|
July 13, 2004
Immunological memory to viral infection
Mark K Slifka
Frontiers in Immunology
|
May 17, 2014
Vaccine-mediated immunity against dengue and the potential for long-term protection against disease
Mark K Slifka
Blood
|
October 9, 2004
Differential regulation of virus-specific T-cell effector functions following activation by peptide or innate cytokines
Carol Beadling, Mark K Slifka
Archivum Immunologiae Et Therapiae Experimentalis
|
April 28, 2006
Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27
Carol Beadling, Mark K Slifka
Viral Immunology
|
September 22, 2006
Keystone conference on viral immunity: from basic mechanisms to vaccines (X7) and advances in influenza research: from birds to bench to bedside (X8) Steamboat Springs, Colorado March 28-April 2, 2006
Fei Liu, Mark K Slifka
Nature Medicine
|
October 3, 2006
Quantifying viable virus-specific T cells without a priori knowledge of fine epitope specificity
Carol Beadling, Mark K Slifka
Viral Immunology
|
July 23, 2005
Public fear of vaccination: separating fact from fiction
Ian Amanna, Mark K Slifka
Vaccine
|
April 9, 2014
How advances in immunology provide insight into improving vaccine efficacy
Mark K Slifka, Ian Amanna
Page
of 13